FSMDX
Price
$35.98
Change
+$0.22 (+0.62%)
Updated
Jul 3 closing price
Net Assets
42.38B
GVMCX
Price
$47.06
Change
+$0.30 (+0.64%)
Updated
Jul 3 closing price
Net Assets
82.38M
Interact to see
Advertisement

FSMDX vs GVMCX

Header iconFSMDX vs GVMCX Comparison
Open Charts FSMDX vs GVMCXBanner chart's image
Fidelity Mid Cap Index
Price$35.98
Change+$0.22 (+0.62%)
VolumeN/A
Net Assets42.38B
Government Street Opportunities
Price$47.06
Change+$0.30 (+0.64%)
VolumeN/A
Net Assets82.38M
FSMDX vs GVMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. GVMCX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and GVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 42.4B vs. GVMCX (82.4M). FSMDX pays higher dividends than GVMCX: FSMDX (1.31) vs GVMCX (0.57). FSMDX was incepted earlier than GVMCX: FSMDX (14 years) vs GVMCX (22 years). GVMCX (1.06) is less costly to investors than FSMDX (0.03). GVMCX is a more actively managed with annual turnover of: 9.00 vs. FSMDX (8.00). FSMDX has a lower initial minimum investment than GVMCX: FSMDX (0) vs GVMCX (5000). FSMDX annual gain was more profitable for investors over the last year : 15.74 vs. GVMCX (7.04). FSMDX return over 5 years is better than : 77.61 vs. GVMCX (72.98).
FSMDXGVMCXFSMDX / GVMCX
Total Expense Ratio0.031.062%
Annual Report Gross Expense Ratio0.031.062%
Fund Existence14 years22 years-
Gain YTD6.1495.404114%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets42.4B82.4M51,456%
Annual Yield % from dividends1.310.57231%
Returns for 1 year15.747.04224%
Returns for 3 years47.5341.85114%
Returns for 5 years77.6172.98106%
Returns for 10 years122.19125.3897%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANRO2.350.05
+2.17%
Alto Neuroscience
NYMTL21.51N/A
N/A
New York Mortgage Trust
ARMK42.79-0.19
-0.44%
ARAMARK
SWBI8.90-0.04
-0.45%
Smith & Wesson Brands
WERN29.07-0.18
-0.62%
Werner Enterprises